Two Sigma Investments’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-198,933
Closed -$120K 4062
2025
Q3
$120K Sell
198,933
-395,601
-67% -$186K ﹤0.01% 3443
2025
Q2
$185K Sell
594,534
-366,053
-38% -$142K ﹤0.01% 2927
2025
Q1
$470K Buy
960,587
+666,777
+227% +$393K ﹤0.01% 2543
2024
Q4
$252K Buy
+293,810
New +$1.84M ﹤0.01% 2801
2024
Q3
Sell
-43,338
Closed -$202K 3103
2024
Q2
$202K Sell
43,338
-111,820
-72% -$529K ﹤0.01% 2729
2024
Q1
$1.06M Sell
155,158
-130,839
-46% -$587K ﹤0.01% 1929
2023
Q4
$958K Buy
285,997
+216,646
+312% +$539K ﹤0.01% 2108
2023
Q3
$173K Buy
69,351
+44,797
+182% +$73.8K ﹤0.01% 2666
2023
Q2
$31.4K Sell
24,554
-64,595
-72% -$85.7K ﹤0.01% 2875
2023
Q1
$72.3K Sell
89,149
-88,624
-50% -$87.3K ﹤0.01% 2710
2022
Q4
$135K Sell
177,773
-3,828
-2% -$3.03K ﹤0.01% 2465
2022
Q3
$169K Buy
181,601
+3,350
+2% +$4.02K ﹤0.01% 2144
2022
Q2
$169K Sell
178,251
-102,022
-36% -$167K ﹤0.01% 2193
2022
Q1
$591K Buy
280,273
+251,842
+886% +$675K ﹤0.01% 1941
2021
Q4
$254K Sell
28,431
-703
-2% -$9.23K ﹤0.01% 3760
2021
Q3
$484K Buy
29,134
+18,643
+178% +$322K ﹤0.01% 3294
2021
Q2
$218K Buy
+10,491
New +$199K ﹤0.01% 3729
2020
Q4
Sell
-27,363
Closed -$568K 3311
2020
Q3
$568K Buy
+27,363
New +$711K ﹤0.01% 2149
2020
Q2
Sell
-7,834
Closed -$256K 2914
2020
Q1
$256K Buy
+7,834
New +$317K ﹤0.01% 2446

Other funds holding APLT

Two Sigma Investments's APLT Position: Q4 2025 in Review

Two Sigma Investments sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 198,933 shares — an estimated $120K sold.

Two Sigma Investments first reported a position in APLT in Q1 2020 and held it in 19 quarters. The position peaked at $1.06M in Q1 2024. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Two Sigma Investments reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 198,933 Applied Therapeutics shares in Q4 2025, an estimated $120K.
  • Two Sigma Investments first reported a position in Applied Therapeutics in Q1 2020 and held it in 19 quarters.
  • Two Sigma Investments's Applied Therapeutics position peaked at $1.06M in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.